From emerging biotech firms to the largest global pharmaceutical companies, IQVIA's Connected Intelligence approach to Clinical Development helps you match the pace of innovation with integrated solutions and gives you the flexibility to match capabilities precisely with research needs.
We’re committed to providing solutions that help you innovate with confidence, maximize opportunities, and ultimately drive patient outcomes forward. IQVIA’s Connected Intelligence connects you to innovative trial solutions like precision site selection, centralized monitoring, automated safety case processing and global regulatory expertise.
Discover how risk-based and centralized monitoring can facilitate digital trial management and improve oversight, cost-effectiveness and patient safety.
Assess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
Identify the best performing sites for your trial in less time with new machine learning and predictive modeling methods.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
Access central labs around the globe through Q2 Solutions, a wholly owned subsidiary of IQVIA.
Get in touch today to discover the right solutions for you.
We are pleased to speak with you during our standard business hours.
U.S. Toll-Free only
+1 866 267 4479
For international call please find a number in ourtoll-free list.